
Developing a potential best-in-class anti-OX40 treatment | ImageneBio
2025年8月1日 · ImageneBio is a clinical-stage biotechnology company developing therapeutics for patients who have immunological, autoimmune and inflammatory diseases. IMG-007 is our next …
A clinical-stage biotechnology company dedicated to developing ...
ImageneBio is a clinical-stage biotechnology company dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases with differentiated clinical profiles. Our …
- [PDF]
IMAGENEBIO, INC.
I. Purpose and Scope The Board of Directors of ImageneBio, Inc. (together with its subsidiaries, the “Company”) has adopted this Code of Business Conduct and Ethics (this “Code”) to aid the …
The members of the Nominating Committee shall be appointed annually by the Board and may be replaced or removed by the Board at any time with or without cause. Resignation or removal of a …
- [PDF]
IMAGENEBIO, INC.
CORPORATE GOVERNANCE GUIDELINES The Board of Directors (the “Board”) of ImageneBio, Inc. (the “Company”) has adopted these corporate governance guidelines to assist and guide the Board …
Each member of the Audit Committee shall be able to read and understand fundamental financial statements, including a company’s balance sheet, income statement, and cash flow statement. At …